Explore journal overview, editorial leadership, indexing, articles in press, latest published work, and highlights from previous issues.
Drug design often termed as rational drug design or rational design. It is a process of finding new medications based on the knowledge of a biological target. Drug design involves the design of molecules that are complementary in shape and charge to the biomolecular target with which they interact and therefore will bind to it. Sometimes drug design depends on computer modeling techniques known as computer-aided drug design. Drug design that relies on the knowledge of the three-dimensional structure of the biomolecular target is known as structure-based drug design.
Edelweiss Pharma Analytica Acta is a peer reviewed Open Access journal that aims to publish most complete and reliable source of information on the findings and current developments in the form of case reports, original research and review articles, and short communications. All the articles related to pharmaceutical science are published online and are available to the readers worldwide without any Subscription Charge. Edelweiss Pharma Analytica Acta is the Journal maintained by Edelweiss publications, which ensures of Rapid Peer review with the help of its Editorial Board.
Researchers, authors, reviewers, and readers can use this page to find journal resources connected with Drug Design, including published articles, related academic topics, current issue content, archive material, and manuscript submission information.
Related article links for Drug Design will appear here as matching content is published in Edelweiss Pharma Analytic Acta (ISSN: 2689-9477). Readers can also browse the journal archive and current issue for connected research.
